{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:50:03Z","timestamp":1785307803554,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,23]]},"DOI":"10.7759\/cureus.49313","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:18:25Z","timestamp":1700799505000},"source":"Crossref","is-referenced-by-count":6,"title":["Idiopathic Thrombocytopenic Purpura: Current Limitations and Management"],"prefix":"10.7759","author":[{"given":"Rakshanda","family":"Thakre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Gharde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Raghuwanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2019-0014","article-title":"Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease","volume":"57","author":"Onis\u00e2i M","year":"2019","unstructured":"Onis\u00e2i M, Vl\u0103d\u0103reanu AM, Sp\u00eenu A, G\u0103man M, Bumbea H. Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease. Rom J Intern Med. 2019, 57:273-83. 10.2478\/rjim-2019-0014","journal-title":"Rom J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2011.648245","article-title":"Perinatal outcome for pregnancies complicated with thrombocytopenia","volume":"25","author":"Onis\u00e2i M","year":"2012","unstructured":"Onis\u00e2i M, Vl\u0103d\u0103reanu AM, Delcea C, et al.. Perinatal outcome for pregnancies complicated with thrombocytopenia. J Matern Fetal Neonatal Med. 2012, 25:1622-6. 10.3109\/14767058.2011.648245","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura","volume":"77","author":"Cortelazzo S","year":"1991","unstructured":"Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood. 1991, 77:31-3. 10.1182\/blood.V77.1.31.31","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-138487","article-title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura","volume":"112","author":"Neunert CE","year":"2008","unstructured":"Neunert CE, Buchanan GR, Imbach P, et al.. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008, 112:4003-8. 10.1182\/blood-2008-03-138487","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56120667","article-title":"Immune thrombocytopenia (ITP): Current limitations in patient management","volume":"56","author":"Terrell DR","year":"2020","unstructured":"Terrell DR, Neunert CE, Cooper N, et al.. Immune thrombocytopenia (ITP): Current limitations in patient management. Medicina (Kaunas). 2020, 56:667. 10.3390\/medicina56120667","journal-title":"Medicina (Kaunas)"},{"key":"ref7","unstructured":"Platelet Disorder Support Association - for People with ITP - Living with ITP. (2023). Accessed. November 5, 2023: https:\/\/pdsa.org\/about-itp\/living-with-itp.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1758546","article-title":"Possible targets to reduce fatigue in chronic immune thrombocytopenia patients - An explorative study","volume":"6","author":"van Dijk WE","year":"2022","unstructured":"van Dijk WE, Nap-van der Vlist MM, Knoop H, Schutgens RE. Possible targets to reduce fatigue in chronic immune thrombocytopenia patients - An explorative study. TH Open. 2022, 6:e387-95. 10.1055\/s-0042-1758546","journal-title":"TH Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15993","article-title":"Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: Short report from a longitudinal study","volume":"186","author":"Mitchell E","year":"2019","unstructured":"Mitchell E, Frith J, Newton J. Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: Short report from a longitudinal study. Br J Haematol. 2019, 186:777-81. 10.1111\/bjh.15993","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-11","article-title":"A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation","volume":"5","author":"Mathias SD","year":"2007","unstructured":"Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation. Health Qual Life Outcomes. 2007, 5:11. 10.1186\/1477-7525-5-11","journal-title":"Health Qual Life Outcomes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24257","article-title":"Quality of life in childhood immune thrombocytopenia: International validation of the kids' ITP tools","volume":"60","author":"Klaassen RJ","year":"2013","unstructured":"Klaassen RJ, Blanchette V, Burke TA, et al.. Quality of life in childhood immune thrombocytopenia: International validation of the kids' ITP tools. Pediatr Blood Cancer. 2013, 60:95-100. 10.1002\/pbc.24257","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003599","article-title":"Identifying and treating refractory ITP: Difficulty in diagnosis and role of combination treatment","volume":"135","author":"Miltiadous O","year":"2020","unstructured":"Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: Difficulty in diagnosis and role of combination treatment. Blood. 2020, 135:472-90. 10.1182\/blood.2019003599","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K","article-title":"Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)","volume":"65","author":"Paolini R","year":"2000","unstructured":"Paolini R, Fabris F, Cella G. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP). Am J Hematol. 2000, 65:177-8. 10.1002\/1096-8652(200010)65:2&lt;177::AID-AJH17&gt;3.0.CO;2-K","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari G","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013, 27:495-520. 10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: Pathogenic and clinical diversity","volume":"113","author":"Cines DB","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood. 2009, 113:6511-21. 10.1182\/blood-2009-01-129155","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas FP","year":"2004","unstructured":"Panitsas FP, Theodoropoulou M, Kouraklis A, et al.. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004, 103:2645-7. 10.1182\/blood-2003-07-2268","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0172","article-title":"Immune pathophysiology of autoimmune thrombocytopenic purpura","volume":"16","author":"Semple JW","year":"2002","unstructured":"Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 2002, 16:9-12. 10.1054\/blre.2001.0172","journal-title":"Blood Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.1.130","article-title":"Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura","volume":"98","author":"Kuwana M","year":"2001","unstructured":"Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, Ikeda Y. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood. 2001, 98:130-9. 10.1182\/blood.v98.1.130","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody","volume":"102","author":"Kuwana M","year":"1998","unstructured":"Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest. 1998, 102:1393-402. 10.1172\/JCI4238","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig KW","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995, 80:695-705. 10.1016\/0092-8674(95)90348-8","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia S","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017, 16:620-32. 10.1016\/j.autrev.2017.04.012","journal-title":"Autoimmun Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26045","article-title":"Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment","volume":"96","author":"Cooper N","year":"2021","unstructured":"Cooper N, Kruse A, Kruse C, et al.. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021, 96:188-98. 10.1002\/ajh.26045","journal-title":"Am J Hematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.03.007","article-title":"Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopenia","volume":"50 Suppl 1","author":"Kirsch M","year":"2013","unstructured":"Kirsch M, Klaassen RJ, De Geest S, Matzdorff A, Ionova T, Dobbels F. Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopenia. Semin Hematol. 2013, 50 Suppl 1:S39-42. 10.1053\/j.seminhematol.2013.03.007","journal-title":"Semin Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.01.037","article-title":"Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The Kids' ITP tools","volume":"150","author":"Klaassen RJ","year":"2007","unstructured":"Klaassen RJ, Blanchette VS, Barnard D, et al.. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The Kids' ITP tools. J Pediatr. 2007, 150:510-5, 515.e1. 10.1016\/j.jpeds.2007.01.037","journal-title":"J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002625","article-title":"Romiplostim or standard of care in patients with immune thrombocytopenia","volume":"363","author":"Kuter DJ","year":"2010","unstructured":"Kuter DJ, Rummel M, Boccia R, et al.. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 2010, 363:1889-99. 10.1056\/NEJMoa1002625","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial","volume":"371","author":"Kuter DJ","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM, et al.. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet. 2008, 371:395-403. 10.1016\/S0140-6736(08)60203-2","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14446","article-title":"Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia","volume":"17","author":"Adelborg K","year":"2019","unstructured":"Adelborg K, Kristensen NR, N\u00f8rgaard M, et al.. Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia. J Thromb Haemost. 2019, 17:912-24. 10.1111\/jth.14446","journal-title":"J Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05235.x","article-title":"Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: Results of a prospective study","volume":"127","author":"Bruin M","year":"2004","unstructured":"Bruin M, Bierings M, Uiterwaal C, et al.. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: Results of a prospective study. Br J Haematol. 2004, 127:561-7. 10.1111\/j.1365-2141.2004.05235.x","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570127","article-title":"Clinical and laboratory predictors of chronic immune thrombocytopenia in children: A systematic review and meta-analysis","volume":"124","author":"Heitink-Poll\u00e9 KM","year":"2014","unstructured":"Heitink-Poll\u00e9 KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: A systematic review and meta-analysis. Blood. 2014, 124:3295-307. 10.1182\/blood-2014-04-570127","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1640870","article-title":"Managing ITP and thrombocytopenia in pregnancy","volume":"31","author":"Eslick R","year":"2020","unstructured":"Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets. 2020, 31:300-6. 10.1080\/09537104.2019.1640870","journal-title":"Platelets"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.405","article-title":"Pediatric ITP: Is it different from adult ITP?","volume":"2018","author":"Despotovic JM","year":"2018","unstructured":"Despotovic JM, Grimes AB. Pediatric ITP: Is it different from adult ITP?. Hematol Am Soc Hematol Educ Program. 2018, 2018:405-11. 10.1182\/asheducation-2018.1.405","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25086","article-title":"A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up","volume":"93","author":"Schifferli A","year":"2018","unstructured":"Schifferli A, Holbro A, Chitlur M, et al.. A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up. Am J Hematol. 2018, 93:751-9. 10.1002\/ajh.25086","journal-title":"Am J Hematol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.050799","article-title":"Newly diagnosed immune thrombocytopenia in children and adults: A comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group","volume":"96","author":"K\u00fchne T","year":"2011","unstructured":"K\u00fchne T, Berchtold W, Michaels LA, et al.. Newly diagnosed immune thrombocytopenia in children and adults: A comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011, 96:1831-7. 10.3324\/haematol.2011.050799","journal-title":"Haematologica"},{"key":"ref34","article-title":"Immune thrombocytopenic purpura in children and adults: A comparative retrospective study in Iran","volume":"8","author":"Saeidi S","year":"2014","unstructured":"Saeidi S, Jaseb K, Asnafi AA, et al.. Immune thrombocytopenic purpura in children and adults: A comparative retrospective study in Iran. Int J Hematol Oncol Stem Cell Res. 2014, 8:30-6.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022043","article-title":"Management of immune thrombocytopenia: 2022 update of Korean experts recommendations","volume":"57","author":"Park YH","year":"2022","unstructured":"Park YH, Kim DY, Kim S, et al.. Management of immune thrombocytopenia: 2022 update of Korean experts recommendations. Blood Res. 2022, 57:20-8. 10.5045\/br.2022.2022043","journal-title":"Blood Res"},{"key":"ref36","article-title":"Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia","volume":"3","author":"Cheung E","year":"2009","unstructured":"Cheung E, Liebman HA. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics. 2009, 3:57-62.","journal-title":"Biologics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220304","article-title":"Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia","volume":"22","author":"Salama A","year":"1986","unstructured":"Salama A, Kiefel V, Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol. 1986, 22:241-50. 10.1002\/ajh.2830220304","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32835e5337","article-title":"A comparison of intravenous immunoglobulin (2 g\/kg totally) and single doses of anti-D immunoglobulin at 50 \u03bcg\/kg, 75 \u03bcg\/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience","volume":"24","author":"Alioglu B","year":"2013","unstructured":"Alioglu B, Ercan S, Tapci AE, Zengin T, Yazarli E, Dallar Y. A comparison of intravenous immunoglobulin (2 g\/kg totally) and single doses of anti-D immunoglobulin at 50 \u03bcg\/kg, 75 \u03bcg\/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience. Blood Coagul Fibrinolysis. 2013, 24:505-9. 10.1097\/MBC.0b013e32835e5337","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref39","unstructured":"Best ITP treatment in India | Ayurvedic treatment of ITP. Sree Subramania Ayurvedic Nursing Home. Accessed. November 6, 2023: https:\/\/ayurvedichospitalkerala.com\/conditions\/itp-treatment\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184687-idiopathic-thrombocytopenic-purpura-current-limitations-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:11Z","timestamp":1707509411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184687-idiopathic-thrombocytopenic-purpura-current-limitations-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.49313","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}